EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding the Molecular Data of DICER1 ‐Related Tumor Predisposition: Novel Germline Variants in an Argentine Pediatric Cohort

Sofía Trobo iD, Natalia Pérez Garrido iD, Pablo Ramírez iD, Fiorella Tesan iD, Elisa Vaiani iD, Noelia Dujovne iD, Natalia Gazek iD, Jessica Lopez Martí iD, Mariana Lavia iD, Guido Felizzia iD, Victoria Pringles iD, Melisa Agotegaray iD und 4 weitere

Human Mutation · 2026

DOI: 10.1155/humu/3621830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2026. Verfasst von Sofía Trobo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Molecular Laboratory Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina. Hauptthemen laut MEDLINE: Ribonuclease III, DEAD-box RNA Helicases, Germ-Line Mutation, Genetic Predisposition to Disease. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objective DICER1 ‐related tumor predisposition is a rare hereditary tumor predisposition disorder characterized by autosomal dominant inheritance, reduced penetrance, and variable expressivity. This study is aimed at describing the clinical and molecular spectrum of DICER1 ‐related tumor predisposition in an Argentine pediatric cohort. Design and Methods Seventeen unrelated patients with DICER1 ‐related tumor predisposition and 54 relatives were evaluated at “Prof. Dr. J. P. Garrahan” Pediatric Hospital (Buenos Aires, Argentina) between 2014 and 2024. Germline and somatic DICER1 variants were analyzed using Sanger or next‐generation sequencing. Functional assays were performed for selected intronic variants. Three samples of poorly differentiated thyroid carcinoma were also included.

Results

Sixteen distinct germline variants were identified in the 17 index cases, including 12 novel alterations (75%). One quarter of the variants were de novo. Thyroid involvement, particularly multinodular goiter and papillary thyroid carcinoma, was the most common presentation and frequently coexisted with ovarian Sertoli–Leydig cell tumors or embryonal rhabdomyosarcoma. Two novel intronic variants were confirmed to affect splicing by RT‐PCR. Somatic “hotspot” mutations in exons 24–25 (RNase IIIb domain) were detected in most tumors, consistent with the two‐hit model. The identification of asymptomatic carriers enabled early surveillance and preventive interventions.

Conclusions

This study expands the molecular spectrum of germline DICER1 variants, reinforces the predominance of thyroid involvement, and highlights the value of molecular testing for diagnosis, genetic counseling, and early intervention. Ethical considerations regarding surveillance and management of asymptomatic carriers remain an important area in need of future guidance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ribonuclease IIIDEAD-box RNA HelicasesGerm-Line MutationGenetic Predisposition to DiseaseHumansFemaleArgentinaChildMaleAdolescentChild, PreschoolThyroid NeoplasmsCohort StudiesInfantIntrons

Substanzen

Ribonuclease IIIDICER1 protein, humanDEAD-box RNA Helicases

Autor:innen und Institutionen

  • Endocrinology Molecular Laboratory Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina.
  • Endocrinology Service Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina.
  • Pathology Service Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina.
  • Genetics Service Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina.
  • Oncology Service Hospital de Pediatría Prof. Dr. Juan P. Garrahan Buenos Aires Argentina.
  • Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) Buenos Aires Argentina conicet.gov.ar.

ORCID-Profile: Sofía Trobo, Natalia Pérez Garrido, Pablo Ramírez, Fiorella Tesan, Elisa Vaiani, Noelia Dujovne, Natalia Gazek, Jessica Lopez Martí, Mariana Lavia, Guido Felizzia, Victoria Pringles, Melisa Agotegaray, Nora Saraco, Marta Ciaccio, Alicia Belgorosky, Roxana Marino

Zitieren

APA

Trobo, S., Garrido, N. P., Ramírez, P., Tesan, F., Vaiani, E., Dujovne, N., Gazek, N., Martí, J. L., Lavia, M., Felizzia, G., Pringles, V., Agotegaray, M., Saraco, N., Ciaccio, M., Belgorosky, A., & Marino, R. (2026). Expanding the Molecular Data of DICER1 ‐Related Tumor Predisposition: Novel Germline Variants in an Argentine Pediatric Cohort. Human Mutation. https://doi.org/10.1155/humu/3621830

Vancouver

Trobo S, Garrido NP, Ramírez P, Tesan F, Vaiani E, Dujovne N, et al. Expanding the Molecular Data of DICER1 ‐Related Tumor Predisposition: Novel Germline Variants in an Argentine Pediatric Cohort. Human Mutation. 2026. doi:10.1155/humu/3621830

BibTeX
@article{Trobo2026,
  author = {Trobo, Sofía and Garrido, Natalia Pérez and Ramírez, Pablo and Tesan, Fiorella and Vaiani, Elisa and Dujovne, Noelia and Gazek, Natalia and Martí, Jessica Lopez and Lavia, Mariana and Felizzia, Guido and Pringles, Victoria and Agotegaray, Melisa and Saraco, Nora and Ciaccio, Marta and Belgorosky, Alicia and Marino, Roxana},
  title = {Expanding the Molecular Data of DICER1 ‐Related Tumor Predisposition: Novel Germline Variants in an Argentine Pediatric Cohort},
  journal = {Human Mutation},
  year = {2026},
  doi = {10.1155/humu/3621830}
}
Kostenlos starten →